Clinical Trial Update: Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating subcutaneous immunotherapy in patients with allergic rhinoconjunctivitis sensitized to Dermatophagoides pteronyssinus (DPT) has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinoconjunctivitis

Drugs mentioned

• Subcutaneous immunotherapy (DPT-sensitized)

Snippet

Sponsor: Roxall Medicina España S.A | Conditions: Allergic Rhinoconjunctivitis | Phase 1 | Status: COMPLETED | Results posted: 2019-05-06